WUXI BIO (HKEX: 02269) has announced a significant share repurchase transaction.

The company disclosed that on June 12, 2026, it utilized approximately HK$99.78 million to repurchase 3.269 million of its own shares.

In a separate corporate action on the same date, the company issued 21,000 new shares.

These shares were issued pursuant to the exercise of options under a pre-IPO share option scheme adopted on January 5, 2016, and subsequently amended on August 10, 2016.